{"id":140837,"date":"2014-09-11T03:44:32","date_gmt":"2014-09-11T07:44:32","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/tory-williams-combats-controversy-surrounding-stem-cell-therapy-with-new-book.php"},"modified":"2014-09-11T03:44:32","modified_gmt":"2014-09-11T07:44:32","slug":"tory-williams-combats-controversy-surrounding-stem-cell-therapy-with-new-book","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-engineering\/tory-williams-combats-controversy-surrounding-stem-cell-therapy-with-new-book.php","title":{"rendered":"Tory Williams combats controversy surrounding stem cell therapy with new book"},"content":{"rendered":"<p><p>    PUBLIC RELEASE DATE:  <\/p>\n<p>    10-Sep-2014  <\/p>\n<p>    Contact: Melanie Scharler    917-340-6492    Mary Ann Liebert, Inc.\/Genetic    Engineering News    @LiebertOnline<\/p>\n<p>    (New Rochelle, New York) September 10, 2014 - Mary Ann Liebert,    Inc., leading publisher of over 80 science, technology, and    medical publications, announced today the launch of first time    hard cover title Inevitable Collision: The Inspiring Story that    Brought Stem Cell Research to Conservative America, in an    effort to bring awareness to the growing conversation and    debate surrounding stem cell research and regenerative    medicine.  <\/p>\n<p>    Written by Tory Williams, author, advocate, mom, and co-founder    of the Alabama Institute of Medicine (AIM), Inevitable    Collision is a human-interest story that details the    controversial Geron Trial, the first human embryonic stem cell    trial for patients with paralysis, and thoughtfully documents    the first and fifth patients, TJ Atchison and Katie Sharify.    The book features provocative conversations with doctors,    medical researchers, and scientists including Dr. Hans    Keirstead, the famous scientist whose groundbreaking research    helped rats to overcome paralysis through stem cell treatments    and introduced the therapy to humans, and helps inform the    public conversation by presenting the facts and opportunities    surrounding stem cell research and therapy.  <\/p>\n<p>    \"Tory's personal journey of advocacy, perseverance, and    commitment to the advance-ment of stem cell research and its    application is an important and relevant testament to the stem    cell conversation at large,\" said Mary Ann Liebert, president    and CEO of the company that bears her name. \"Inevitable    Collision will strongly resonate with the six million Americans    suffering from paralysis, a quarter of which are the result of    a spinal cord injury. In a very readable and compelling style,    Williams has brought the much needed human voice to the    oftentimes controversial and misunderstood topic of stem cell    technology. It is an important read for the public,    legislators, and patients and their families, as well as for    researchers and members of the health care community. This book    will make a difference!\"  <\/p>\n<p>    Compared to the narrative and journalistic writing style of The    Immortal Life of Henrietta Lacks, Inevitable Collision explains    in reader-friendly terms how stem cells work, and why they are    considered important tools in finding a cure for paralysis and    other disabilities. The book also details author Tory Williams'    physical and emotional struggles while raising funding and    public awareness surrounding embryonic stem cell research    across the nation.  <\/p>\n<p>    \"Through this book I hope to bridge the gap between science and    religion and raise awareness of the importance and power of    stem cell research,\" said Tory Williams. \"This book is intended    not only for patients who suffer from paralysis and diseases    such as cancer and Parkinson's, but for everyone affected by    these afflictions, directly and indirectly.\"  <\/p>\n<p>    The launch comes on the heels of the California Institute for    Regenerative Medicine's (CIRM) recent announcement green    lighting the follow-up phase to the Geron clinical trial as    approved by the FDA.  <\/p>\n<p>    Inevitable Collision's 208 pages plus 8-page photo spread    retails at $21.95 for the hard-back and $9.99 for the e-book    and includes an afterword written by Roman Reed, a tire-less    patient advocate who was paralyzed from a sports injury 20    years ago. Roman is the Founder of the Roman Reed Foundation    and Roman's Law, which was the impetus for California's    groundbreaking stem cell program.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Excerpt from:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.eurekalert.org\/pub_releases\/2014-09\/mali-twc091014.php\/RK=0\/RS=cQGYieZsMtbStKvW3ASczKIWAsk-\" title=\"Tory Williams combats controversy surrounding stem cell therapy with new book\">Tory Williams combats controversy surrounding stem cell therapy with new book<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> PUBLIC RELEASE DATE: 10-Sep-2014 Contact: Melanie Scharler 917-340-6492 Mary Ann Liebert, Inc.\/Genetic Engineering News @LiebertOnline (New Rochelle, New York) September 10, 2014 - Mary Ann Liebert, Inc., leading publisher of over 80 science, technology, and medical publications, announced today the launch of first time hard cover title Inevitable Collision: The Inspiring Story that Brought Stem Cell Research to Conservative America, in an effort to bring awareness to the growing conversation and debate surrounding stem cell research and regenerative medicine. Written by Tory Williams, author, advocate, mom, and co-founder of the Alabama Institute of Medicine (AIM), Inevitable Collision is a human-interest story that details the controversial Geron Trial, the first human embryonic stem cell trial for patients with paralysis, and thoughtfully documents the first and fifth patients, TJ Atchison and Katie Sharify.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-engineering\/tory-williams-combats-controversy-surrounding-stem-cell-therapy-with-new-book.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[3],"tags":[],"class_list":["post-140837","post","type-post","status-publish","format-standard","hentry","category-genetic-engineering"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/140837"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=140837"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/140837\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=140837"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=140837"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=140837"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}